This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Biopsy Devices Market Is Expected To Reach USD 2.1 Billion Globally In 2018: Transparency Market Research

ALBANY, New York, March 26, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( http://www.transparencymarketresearch.com) " Biopsy Devices Market (Disposable & Reusable Needles, Hot & Cold Forceps, Needle-based Biopsy Guns, VAB, CNB, FNAB Devices, Guidance Systems)  -  Global Industry Analysis, Size, Sha re, Growth, Trends and Forecast, 2012  -  2018, " in 2011, the global biopsy devices market was valued at USD 1.3 billion and is expected to grow at a CAGR of 6.6% from 2012 to 2018, to reach an estimated value of USD 2.1 billion in 2018.

Browse the full report at  http://www.transparencymarketresearch.com/biopsy-devices-market.html

The market is driven mainly by rising worldwide cancer incidence, increasing preference for minimally invasive procedures and growing awareness regarding frequent screenings. People are more aware regarding development of cancer and its early diagnosis, thereby opting for regular screenings and check-ups. The demand for disposable devices and needles is on the rise, as patients are now highly conscious about issues such as transmission of infectious diseases. Cancer being a fatal disease if not diagnosed early, patients do not hesitate to opt for expensive surgeries. All these factors are expected to drive the growth of the market during the forecast period 2012 to 2018.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/medical-gases-and-equipment.html

http://www.transparencymarketresearch.com/radiofrequency-ablation-devices.html

http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html

http://www.transparencymarketresearch.com/interventional-cardiology-devices.html

http://www.transparencymarketresearch.com/wound-dressing-market.html

Needle-based guns are identified as the fastest growing segment with a CAGR of 8%. Within this segment, preference for vacuum-assisted biopsy devices is higher due to its high efficiency and minimally invasive nature. The biopsy guidance systems segment accounted for the largest market share in 2011; the market for these devices was valued at USD 607.5 million. This segment is expected to continue to lead the market till 2018, in terms of revenue.

Geographically, North America accounted for the largest share in this market in 2011. This is mainly due to the large patient population, availability of advanced medical technologies and strong presence of leading market players. However, with a healthy CAGR of 10.5%, Asia is expected to emerge as the fastest growing regional market on account of the rapidly growing overall population as well as aging population, increasing incidence of cancer, rising disposable incomes of patients and growing economies.

Related & Recently Published Reports by Transparency Market Research

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,001.22 -38.27 -0.22%
S&P 500 1,988.40 -3.97 -0.20%
NASDAQ 4,538.5510 +6.4470 0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs